Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000404136

Medchemexpress LLC Navitoclax-piperazine | 2143096-93-7 | 99.7% | 973.63 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY4443250MG

Encompass_Preferred

Navitoclax-piperazine (ABT-263-piperazine) is a Navitoclax analog and BCL-XL inhibitor. It acts as a ligand for the target protein of PROTAC DT2216. This compound can be used with an E3 ubiquitin ligase VHL ligand to synthesize PROTAC DT2216.

  • Functions as a BCL-XL inhibitor.
  • Acts as a ligand for the target protein of PROTAC DT2216.
  • Can be used for the synthesis of PROTAC DT2216.
  • Purity of 99.7%.
  • Supplied as a white to off-white solid.
  • Soluble in DMSO at 125 mg/mL.
  • Detailed storage conditions provided for powder and in solvent.
  • Includes in vivo dissolution protocols.

Catalog No. 50-004-04136


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.